Kangpu Biopharmaceuticals Received CDE Approval for Phase IIb Clinical Trial of KPG-818 in Moderate to Severe Cutaneous Manifestations of SLE
Appknox Launches Storeknox, Revolutionizes Mobile App Security with Continuous Store Monitoring
Celltrion to present six abstracts in inflammatory bowel disease (IBD) at 2025 Digestive Disease Week® (DDW)
Small Lab Co., Ltd., obtains FDA OTC approval. Leading the K-Beauty wave
Sky Labs' CART BP pro at the Heart of New Research on Sleep Apnea and Nocturnal Hypertension
TDH Holdings, Inc. Reports Full Year 2024 Audited Financial Results
WOORI FINANCIAL GROUP INC. FILES ITS ANNUAL REPORT ON FORM 20-F
JCET Reports Q1 2025 Revenue Growth of 36.4% and Net Profit Growth of 50.4%
